Critical heart condition during pregnancy : critical care obstetrics.
Cardiac Critical Illness is a volume in the Critical Care Obstetrics series.It's a novel reference to educate physicians, nurses, and all allied healthcare personnel caring for pregnant women with various health compromises specific to cardiac complications.
Saved in:
| Format: | Electronisk eBog |
|---|---|
| Sprog: | engelsk |
| Udgivet: |
[S.l.] :
Academic Press,
2024.
|
| Serier: | Criticial care in obstetrics
|
| Fag: | |
| Online adgang: | ScienceDirect |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
MARC
| LEADER | 00000cam a22000007a 4500 | ||
|---|---|---|---|
| 001 | on1452826488 | ||
| 003 | OCoLC | ||
| 005 | 20260915095215.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 240822s2024 xx o 000 0 eng d | ||
| 040 | |a YDX |b eng |c YDX |d OPELS |d OCLCO |d UKAHL |d N$T |d OCLCQ |d UKMGB |d OCLCL |d SFB |d OCLCF |d OCLCO | ||
| 015 | |a GBC477976 |2 bnb | ||
| 016 | 7 | |a 300198096 |2 Uk | |
| 019 | |a 1453416681 | ||
| 020 | |a 9780443220074 |q (electronic bk.) | ||
| 020 | |a 0443220077 |q (electronic bk.) | ||
| 020 | |z 9780443220081 | ||
| 020 | |z 0443220085 | ||
| 024 | 8 | |a CIPO000110022 | |
| 035 | |a (OCoLC)1452826488 |z (OCoLC)1453416681 | ||
| 050 | 4 | |a RG580.H4 | |
| 082 | 0 | 4 | |a 618.3/61 |2 23/eng/20240903 |1 https://id.oclc.org/worldcat/ddc/E3pPP4hBwyMWXpcv4Gw4CQK8hY |
| 245 | 0 | 0 | |a Critical heart condition during pregnancy : |b critical care obstetrics. |
| 260 | |a [S.l.] : |b Academic Press, |c 2024. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 490 | 0 | |a Criticial care in obstetrics | |
| 505 | 0 | |a Front Cover -- Critical Heart Condition During Pregnancy -- Critical Heart Condition During Pregnancy: Critical Care Obstetrics -- Copyright -- Contents -- Contributors -- Preface -- 1 -- The cardio-obstetric team -- Introduction -- Components of the cardio-obstetric team -- Purpose of the cardio-obstetric team -- Preconception assessment of patients with cardiac disease -- mWHO class I -- mWHO class II -- mWHO class II-III -- mWHO class III -- mWHO class IV -- Collaborative antenatal assessment -- Multidisciplinary conferences -- Postdelivery follow-up -- Research and education -- Training -- Developing a cardio-obstetrics service -- Organizational culture and future vision -- Conclusion -- References -- 2 -- Pregnancy induced heart physiological alteration -- Introduction -- Heart remodeling (position and size) -- Heart rate -- Cardiac output -- Blood volume changes -- Systemic vascular resistance -- Arterial blood pressure -- Influence body position -- Conclusion -- References -- 3 -- Critical heart condition during pregnancy -- Physiological changes of pregnancy -- Hypertensive disorders associated with pregnancy -- Hypotensive sintomas de hipotension -- Symptoms and signs in preeclampsia and eclampsia -- Heart valve disease -- Other heart problems that could develop during pregnancy -- Arrhythmias -- References -- 4 -- Anesthesia and analgesia for the critically ill obstetric patient with cardiac disease -- Introduction -- Risk stratification -- WHO group I -- WHO group II -- WHO group III -- WHO group IV -- Identification of heart disease in pregnancy -- Physiological changes during delivery -- Decision-making and delivery planning -- Monitoring -- General principles of anesthetic management -- Analgesia for vaginal delivery -- Neuraxial anesthesia for caesarean section delivery. | |
| 505 | 8 | |a General anesthesia for caesarean section delivery-general principles -- Peripartum cardiovascular support-pharmacological -- Obstructive lesions -- Regurgitant lesions -- Ischemic heart disease -- Pulmonary hypertension -- Acute aortic aneurysm and dissection -- Right-to-left shunt -- Left-to-right shunt -- Peripartum cardiovascular support-nonpharmacological -- Postpartum care -- References -- 5 -- Anticoagulation in pregnancy -- Introduction -- Risk factors for pregnancy-related VTE -- Anticoagulant therapy in pregnancy -- Heparins -- Vitamin K antagonist -- Direct oral anticoagulant -- Danaparoid -- Fondaparinux -- Other anticoagulants -- Indications of anticoagulation in pregnancy -- Preconception management of women already using anticoagulants when planning pregnancy -- Previous VTE -- Women with Mechanical heart valve -- Prevention of pregnancy-related VTE -- Women with a personal history of VTE -- Thromboprophylaxis in women with inherited thrombophilia -- Women undergoing assisted reproductive technology -- Thromboprophylaxis after caesarean section -- Prevention of pregnancy loss -- Prevention in women with antiphospholipid Syndrome -- Management of acute venous thromboembolism during pregnancy -- Acute VTE during pregnancy -- Thrombolysis for pulmonary embolism in pregnancy -- Peripartum management -- Anticoagulant therapy in breastfeeding women -- Conclusions -- References -- 6 -- Pregnancy and valvular heart disease -- Introduction -- Hemodynamic changes during pregnancy -- Evaluation and risk assessment -- Mitral stenosis -- Aortic stenosis -- Women with prosthetic valves -- Stenotic valve disease -- Mitral stenosis -- Aortic stenosis -- Regurgitant valve disease -- Delivery and postpartum management -- Anesthetic considerations -- Intrapartum care -- Mode of delivery -- Endocarditis risk -- Postpartum management -- Oxytocic drugs. | |
| 505 | 8 | |a Anticoagulation and hemorrhage -- Lactation -- Contraception -- References -- 7 -- Adult congenital heart disease in pregnancy -- Introduction -- Preconception counseling -- Contraindications to pregnancy -- Determinants of fetal outcome -- Risk of recurrence of congenital heart defects in fetus -- Investigations -- Specific lesions -- Acyanotic congenital heart diseases -- Cyanotic congenital heart disease -- Tetralogy of Fallot -- Transposition of the great arteries -- Truncus arteriosus -- Ebstein's anomaly -- Univentricular heart -- Management -- Antenatal care and prevention of complications -- Cardiac medications during pregnancy -- Thromboembolism and pregnancy -- Delivery -- Antibiotic prophylaxis -- Intensive care management -- Conclusion -- References -- 8 -- Peripartum cardiomyopathy -- Peripartum cardiomyopathy case definition -- Epidemiology -- Risk factors -- Pathophysiology -- Clinical manifestations -- Therapeutic strategies -- Acute phase -- Chronic phase -- References -- 9 -- Acute coronary syndrome during pregnancy -- Incidence and risk factors -- Diagnosis -- Management -- Conclusion -- References -- 10 -- Pulmonary hypertension in pregnancy -- Introduction -- Definition -- Burden of disease -- Physiological changes and impact on PAH -- Diagnosis -- Symptoms/signs -- Risk stratification -- Counseling and contraceptives -- Women who get pregnant -- Approach to treatment -- Supportive measures -- Pharmacological treatment of PAH -- Calcium channel blockers -- Pulmonary hypertension specific therapies -- Endothelin receptor antagonists -- Phosphodiesterase 5 inhibitors and guanylate cyclase stimulators -- Inhaled nitric oxide -- PAH during pregnancy -- Mode of delivery -- Delivery location -- Anesthetic perspective -- RVAD/ECMO/lung transplant -- Postpartum -- Conclusion -- References -- 11 -- Arrythmias in pregnancy and management. | |
| 505 | 8 | |a Introduction -- Cardiovascular adaptations in pregnancy -- Mechanisms of arrhythmia -- Types of arrhythmia during pregnancy -- Supraventricular arrhythmias -- Atrial fibrillation and flutter -- Ventricular arrhythmias -- Bradyarrhythmias -- Approach to the pregnant woman with palpitations -- History -- Investigations -- Principles of management of arrhythmias in pregnancy -- Treatment of specific arrhythmias in pregnancy -- Hemodynamically unstable arrhythmia -- Benign arrhythmias -- Supraventricular tachycardia -- Atrial fibrillation and atrial flutter -- Ventricular tachyarrhythmias -- Invasive interventions -- Postpartum considerations -- Cardiac arrest in pregnancy -- Inherited arrhythmia syndromes -- Fetal arrhythmias in pregnancy -- Tachyarrhythmias -- Bradyarrhythmias -- Conclusions -- References -- 12 -- Endocarditis in pregnancy -- Introduction -- Definition of endocarditis -- History of diagnosis of IE -- Diagnosis of infective endocarditis -- Confirmation of diagnosis-in pregnancy -- Management of IE -- Management of IE for pregnancy -- Treatment -- Antibiotics -- Surgery -- Complications -- Epidemiology of infective endocarditis -- Types of patients -- Risks -- Prevalence -- Conclusion -- References -- 13 -- Cardiopulmonary resuscitation in pregnancy -- Introduction -- Epidemiology of maternal cardiac arrest -- Conduct of resuscitation -- Activation of the resuscitation team -- Basic life support -- Perimortem caesarean section -- Advanced life support -- Iatrogenic causes -- ECMO and ECPR -- Survival and postresuscitation care -- Somatic support -- Human factors and preparation for maternal cardiac arrest -- Conclusions -- References -- 14 -- Cardiac surgery and pregnancy -- Cardiac surgery and pregnancy -- Rheumatic fever -- Physiological changes during pregnancy -- Comprehensive evaluation -- Maternal risk -- Fetal risk. | |
| 505 | 8 | |a Categorization and management of cardiovascular complications during pregnancy -- High-risk -- Intermediate-risk -- Low-risk -- Drugs and pregnancy -- Arrhythmias -- Thrombosis -- Congenital cardiomyopathy -- Shunts -- Bicuspid aorta -- Aortic coarctation -- Pulmonary stenosis -- Eisenmenger -- Tetralogy of Fallot -- Transpocici̤n de grandes arterias (TGA) -- Ebstein's -- Marfan's -- Aortic dissection -- Hypertrophic cardiomyopathy -- Dilated cardiomyopathy -- Peripartum -- Age -- Myocardial infarction -- Rheumatic disease -- Pregnancy and valve replacement -- Conclusion -- References -- 15 -- Heart failure in pregnancy -- Introduction -- General considerations -- Hemodynamic changes during pregnancy -- Hemodynamic changes during labor and delivery -- Pathophysiology -- Myocardial systolic function -- Neurohormonal activation -- Renin-angiotensin-aldosterone system -- Sympathetic nervous system -- Natriuretic peptides -- Antidiuretic hormone (vasopressin) -- Endothelins -- Maternal and fetal risks -- Causes of heart failure during pregnancy -- Clinical signs -- Investigations -- Chest X-ray and ECG -- Echocardiography -- B-type natriuretic peptide -- Treatment -- Drug therapies -- Diuretics -- Vasodilator therapy -- Angiotensin converting enzyme inhibitors -- Beta-blockers -- Spironolactone -- Anticoagulation -- Bromocriptine -- Inotropes -- Mechanical circulatory support -- The mode of delivery -- Prognosis -- References -- 16 -- Cardiovascular medications in critically ill pregnant patients -- Introduction -- Cardiovascular medications during pregnancy -- Antiarrhythmic drugs -- Antihypertensive drugs -- Diuretic in pregnancy -- Anticoagulation and antiplatelet therapy -- Drugs for heart failure -- Drugs for coronary artery disease during pregnancy -- Lipid-lowering agents during pregnancy -- Drugs for pulmonary hypertension during pregnancy. | |
| 520 | |a Cardiac Critical Illness is a volume in the Critical Care Obstetrics series.It's a novel reference to educate physicians, nurses, and all allied healthcare personnel caring for pregnant women with various health compromises specific to cardiac complications. | ||
| 650 | 0 | |a Heart diseases in pregnancy. | |
| 650 | 0 | |a Heart |x Diseases. | |
| 650 | 0 | |a Critical care medicine. | |
| 650 | 2 | |a Heart Diseases |0 (DNLM)D006331 | |
| 650 | 2 | |a Critical Care |0 (DNLM)D003422 | |
| 650 | 6 | |a Cœur |x Maladies, chez la femme enceinte. |0 (CaQQLa)201-0181419 | |
| 650 | 6 | |a Cœur |x Maladies. |0 (CaQQLa)201-0005230 | |
| 650 | 6 | |a Soins intensifs. |0 (CaQQLa)201-0045567 | |
| 650 | 7 | |a Critical care medicine |2 fast |0 (OCoLC)fst00883647 | |
| 650 | 7 | |a Heart |x Diseases |2 fast |0 (OCoLC)fst00953527 | |
| 650 | 7 | |a Heart diseases in pregnancy |2 fast |0 (OCoLC)fst00953720 | |
| 776 | 0 | 8 | |i Print version: |z 0443220085 |z 9780443220081 |w (OCoLC)1399163413 |
| 856 | 4 | 0 | |3 ScienceDirect |u https://www.sciencedirect.com/science/book/9780443220081 |